A pproximately 15 years of experience and tens of thousands of cases have led to a strong knowledge base for advanced laparoscopy. Additionally, decades of gynecologic laparoscopy led to a large experience with patients who underwent diagnostic or relatively straightforward therapeutic procedures. Our experience with and understanding of the effects of carbon dioxide pneumoperitoneum are far from nascent. Nonetheless, a report in this issue of the Journal provides evidence that although pneumoperitoneum appears to be well-tolerated by most patients, significant sequelae and complications can occur in ways not previously recognized.
The deleterious effects of pneumoperitoneum that have been clearly documented include decreased venous return to the right heart, a hypercoagulable state, increased systemic vascular resistance, and compression of capillaries potentially leading to reduced flow in areas such as the renal cortex and surface of the liver. 1, 2 Attempts to attenuate some of these effects have used substances such as a nitric oxide-releasing substance. Some surgeons use routine anticoagulation following splenectomy. Other simple measures have included working with a lower than normal (normal defined as 15 mm Hg) intraperitoneal pressure and keeping operative times to a minimum.
Gasless laparoscopy received significant attention in the early 1990s but failed to receive widespread acceptance. The lack of popularity of gasless laparoscopy was partially the result of the fact that the working space created by gasless retraction devices was inferior to that created by pneumoperitoneum. A greater factor in the reluctance to adopt gasless techniques was the belief by most surgeons that there were few clinically significant deleterious effects of carbon dioxide pneumoperitoneum. Many of these negative effects were known but rarely observed by individual surgeons. This situation is somewhat analogous to the time during which deep venous thrombosis (DVT) prophylaxis was less common, and many surgeons would claim hundreds or thousands of cases performed without witnessing a DVT or pulmonary embolus in any patient. Careful follow up, objective studies, and published results provided the surgical community with a more thorough understanding of the magnitude of the problem. This understanding subsequently led to widespread use of prophylactic measures for patients at risk for DVT.
Ikeda et al present in this issue of Annals of Surgery an article entitled "High Incidence of Thrombosis of the Portal Venous System After Laparoscopic Splenectomy: A Prospective Study With Contrast-Enhanced CT." 3 The widely known and previously published reports of complications of laparoscopic splenectomy rarely mention portal venous thrombosis. There exist scattered reports of this problem, including the publication by Winslowe et al reporting portal venous thrombosis after splenectomy in a retrospective study that included some patients who had undergone laparoscopic splenectomy. 4 Other case reports and small series have mentioned this complication. None report thrombosis rates that approach the magnitude described in this issue of the journal. However, most prior reports failed to routinely screen postsplenectomy patients radiographically.
The authors pose several hypotheses for the markedly higher rate of thrombosis in the laparoscopic patients compared with open splenectomy patients. These hypotheses remain to be proven. Furthermore, the operative groups are not matched regarding diagnoses, which can clearly impact the rate of postoperative thrombosis. Approximately one third of the patients in this study experienced clinically significant thrombosis. Although the absolute number of patients reported with clinically significant complications is small, the potential implications are disturbing. This study demonstrates the need for further evaluation of the specific topic of postsplenectomy portal venous thrombosis in laparoscopic patients and prompts us to ask, "What other similar problems would be detected if all patients were screened postoperatively?" Would routine computed tomography scans or Doppler flow studies following laparoscopic nephrectomy reveal a disturbing incidence of subclinical thrombus formation in the inferior vena cava? Furthermore, at what point do we subject patients to the risks associated with anticoagulation for problems previously unrecognized that are rarely clinically significant?
Our understanding of the impact of pneumoperitoneum on human physiology requires further investigation. We should ask if the responses previously investigated are true for all populations. Are the observed immune responses in young adults applicable to the elderly or pediatric popula-tions? We already possess the knowledge that the elimination of excess carbon dioxide occurs at different rates in the mother and fetus. However, the clinical significance of this phenomenon is undetermined. Likewise, does a laparoscopicassociated hypercoagulable state occur equally in all patient groups regardless of age or underlying diseases or conditions?
The study by Ikeda et al needs to be confirmed in a larger cohort before the surgical community commits to sweeping changes in the perioperative anticoagulation protocols for laparoscopic patients. Because this study points out the incomplete nature of our understanding of the potential sequelae of pneumoperitoneum, its value reaches far beyond the specific topic reported. One would hope that studies such as this would inspire clinicians and investigators to pursue a deeper understanding of an approach that affects several hundred thousand patients each year. We truly have much yet to learn.
